Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Cited by (1,006)

Items 601–700 of 1,006

  1. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case–control cohorts
    Letizia Polito, Patrick G. Kehoe, Annalisa Davin, Luisa Benussi, Roberta Ghidoni, Giuliano Gb. Binetti, Pierluigi Quadri, Ugo Lucca, Mauro Tettamanti, Francesca Clerici et al. · 2012 · Alzheimer s & Dementia
  2. Functional characterization of three single‐nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA–protein interactions
    Bryan Maloney, Yuan‐Wen Ge, Ronald Carl Petersen, John Hardy, Jack T. Rogers, Jordi Pérez‐Tur, Debomoy K. Lahiri · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  3. Association of the aromatase gene with Alzheimer's disease in women
    Helen Butler, Donald R. Warden, Eef Hogervorst, Jiannis Ragoussis, A. David Smith, Donald J. Lehmann · 2009 · Neuroscience Letters
  4. FRMD4A–cytohesin signaling modulates the cellular release of tau
    Xu Yan, Niko-Petteri Nykänen, Cecilia Anna Brunello, Annakaisa Haapasalo, Mikko O. Hiltunen, Riikka‐Liisa Uronen, Henri J. Huttunen · 2016 · Journal of Cell Science
  5. Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer’s Disease Cerebrospinal Fluid Markers
    Panagiotis Alexopoulos, Liang‐Hao Guo, Martina Kratzer, Christine Westerteicher, Alexander Kurz, Robert Perneczky, Alzheimer’s Disease Neuroimaging Initiative · 2011 · Dementia and Geriatric Cognitive Disorders
  6. Binding of Apolipoprotein E Inhibits the Oligomer Growth of Amyloid-β Peptide in Solution as Determined by Fluorescence Cross-correlation Spectroscopy
    Sonny Ly, Robin Altman, Jitka Petrlová, Yu Lin, Silvia Hilt, Thomas R. Huser, Ted A. Laurence, John C. Voss · 2013 · Journal of Biological Chemistry
  7. The Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or Older
    Gerbrand J. Izaks, Ron T. Gansevoort, Aafke M. van der Knaap, Gerjan J Navis, Robin P. F. Dullaart, Joris P. J. Slaets · 2011 · PLoS ONE
  8. Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?
    Md. Mahiuddin Ahmed, Noah R. Johnson, Timothy D. Boyd, Christina M. Coughlan, Heidi J. Chial, Huntington Potter · 2021 · Frontiers in Aging Neuroscience
  9. Methodology for Discovery of Alzheimer's Disease Blood-Based Biomarkers
    Olivier C. Maes, Hyman M. Schipper, Howard Mark Chertkow, Eugenia Wang · 2009 · The Journals of Gerontology Series A
  10. Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals
    Zhenwei Shang, Hongchao Lv, Mingming Zhang, Lian Duan, Situo Wang, Jin Li, Guiyou Liu, Ruijie Zhang, Yongshuai Jiang · 2015 · Oncotarget
  11. A free radical‐generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease
    Marı́a Recuero, Ma Carmen Vicente, Ana Martı́nez-Garcı́a, María C. Ramos, Pedro Carmona‐Sáez, Isabel Sastre, Jesús Aldudo, Elisabet Vilella, Ana Frank, Maria Jesus Bullido et al. · 2009 · Aging Cell
  12. Cognition and nutrition
    John Edward Morley · 2013 · Current Opinion in Clinical Nutrition & Metabolic Care
  13. APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment
    Roger A. Dixon, Correne A. DeCarlo, Stuart W. S. MacDonald, David Vergote, Jack H. Jhamandas, David A. Westaway · 2014 · Frontiers in Aging Neuroscience
  14. Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review
    Daniel F. Carr, Gareth Whiteley, Ana Alfirevic, Munir Pirmohamed, on behalf of the FolATED study team · 2009 · The Pharmacogenomics Journal
  15. Is Abnormal Axonal Transport a Cause, a Contributing Factor or a Consequence of the Neuronal Pathology in Alzheimer‘s Disease?
    Virgil Mureşan, Zoia Ladescu Muresan · 2009 · Future Neurology
  16. A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease
    Ondřej Benek, Laura Aitken, Lukáš Hroch, Kamil Kuča, Frank J. Gunn‐Moore, Kamil Musílek · 2015 · Current Medicinal Chemistry
  17. Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
    Bruce X. W. Wong, Ya Hui Hung, Ashley Ian Bush, James A. Duce · 2014 · Frontiers in Aging Neuroscience
  18. Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-β accumulation modifier
    Takashi Morihara, Noriyuki Hayashi, Mikiko Yokokoji, Hiroyasu Akatsu, Michael A. Silverman, Nobuyuki Kimura, Masahiro Sato, Yuhki Saito, Toshiharu Suzuki, Kanta Yanagida et al. · 2014 · Proceedings of the National Academy of Sciences
  19. Apolipoprotein E Genotype e2: Neuroprotection and Its Limits
    Hyun Kim, Davangere P. Devanand, Scott Carlson, Terry E. Goldberg · 2022 · Frontiers in Aging Neuroscience
  20. PLD3 in Alzheimer’s Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses
    Dengfeng Zhang, Yu Fan, Dong Wang, Rui Bi, Chen Zhang, Yiru Fang, Yong‐Gang Yao · 2015 · Molecular Neurobiology
  21. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales
    James A. R. Nicoll, George M. Savva, Jennifer Stewart, Fiona E. Matthews, Carol Brayne, Paul G. Ince · 2010 · Neuropathology and Applied Neurobiology
  22. Hidden Risk Genes with High-Order Intragenic Epistasis in Alzheimer's Disease
    Jiya Sun, Fuhai Song, Jiajia Wang, Guangchun Han, Zhouxian Bai, Bin Xie, Xuemei Feng, Jianping Jia, Yong Duan, Hongxing Lei · 2014 · Journal of Alzheimer s Disease
  23. Genomic Convergence of Genome‐wide Investigations for Complex Traits
    Georgios D. Kitsios, Elias Zintzaras · 2009 · Annals of Human Genetics
  24. IGF-I gene variability is associated with an increased risk for AD
    Teodoro Vargas, Ana Martı́nez-Garcı́a, Desireé Antequera, Elisabet Vilella, Jordi Clarimón, Ignacio Mateo, Pascual Sánchez‐Juan, Eloy Rodríguez‐Rodríguez, Ana Frank, Marcel Rosich-Estragó et al. · 2010 · Neurobiology of Aging
  25. Conjugal Alzheimer Disease
    Suman Jayadev, Ellen J. Steinbart, Yueh-Yun Chi, Walter A. Kukull, Gerard D. Schellenberg, Thomas D. Bird · 2008 · Archives of Neurology
  26. Genetic Research in Schizophrenia: New Tools and Future Perspectives
    Lars Bertram · 2008 · Schizophrenia Bulletin
  27. Genome‐wide mediation analysis of psychiatric and cognitive traits through imaging phenotypes
    Xuan Bi, Liuqing Yang, Tengfei Li, Baisong Wang, Hongtu Zhu B, Heping Zhang · 2017 · Human Brain Mapping
  28. GAB2 as an Alzheimer Disease Susceptibility Gene
    Brit‐Maren M. Schjeide, Basavaraj V. Hooli, Michele Parkinson, Meghan F. Hogan, Jason R. DiVito, Kristina Mullin, Deborah Blacker, Rudolph E. Tanzi, Lars Bertram · 2009 · Archives of Neurology
  29. Disrupted white matter structural networks in healthy older adult APOE ε4 carriers – An international multicenter DTI study
    Cavedo, Enrica, Lista, Simone, Rojkova, Katrine, Chiesa, Patrizia A., Houot, Marion, Brueggen, Katharina, Blautzik, Janusch, Bokde, Arun L.W., Dubois, Bruno, Barkhof, Frederik et al. · 2017 · Neuroscience
  30. Association of Alzheimer’s related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study
    Alexandre Vivot, M. Maria Glymour, Christophe Tzourio, Philippe Amouyel, Geneviève Chêne, Carole Dufouil · 2015 · Molecular Psychiatry
  31. Functional regulation of Alu element of human angiotensin-converting enzyme gene in neuron cells
    Shyh-Jong Wu, Tusty‐Jiuan Hsieh, Mei‐Chuan Kuo, Mei-Lan Tsai, Ke-Li Tsai, Chun‐Hung Chen, Yuan‐Han Yang · 2013 · Neurobiology of Aging
  32. Alzheimer’s Genetics in the GWAS Era: A Continuing Story of ‘Replications and Refutations’
    Lars Bertram · 2011 · Current Neurology and Neuroscience Reports
  33. Alzheimer’s Disease: Genetic Polymorphisms and Rate of Decline
    Christian Schmidt, Martin Wolff, Nicolas von Ahsen, Inga Zerr · 2012 · Dementia and Geriatric Cognitive Disorders
  34. A Hierarchical Feature and Sample Selection Framework and Its Application for Alzheimer’s Disease Diagnosis
    Le An, Ehsan Adeli, Mingxia Liu, Jun Zhang, Seong–Whan Lee, Dinggang G. Shen · 2017 · Scientific Reports
  35. Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
    Sofia Essayan-Perez, Bo Zhou, Amber M. Nabet, Marius Wernig, Yu‐Wen Alvin Huang · 2019 · Neurobiology of Disease
  36. Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer’s disease
    Caitlin S. Latimer, Nicole F. Liachko · 2021 · GeroScience
  37. Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging
    Duc Diana Le, Lindsay Brown, Kundan Malik, Shin Murakami · 2021 · International Journal of Molecular Sciences
  38. Genetics and epigenetics of Alzheimer's disease
    Kannayiram Alagiakrishnan, Sudeep S. Gill, Andrei D. Fagarasanu · 2012 · Postgraduate Medical Journal
  39. Relationship between Basal Forebrain Resting-State Functional Connectivity and Brain Amyloid-β Deposition in Cognitively Intact Older Adults with Subjective Memory Complaints
    Patrizia Andrea Chiesa, Enrica Cavedo, Michel J. Grothe, Marion Houot, Stefan Johannes Teipel, Marie‐Claude Potier, Marie‐Odile Habert, Simone Lista, Bruno Dubois, Harald Juergen Hampel et al. · 2018 · Radiology
  40. Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein
    Celina Zerbinatti, Joanna M. Cordy, Ci-Di Chen, Maria D. Guillily, Sokreine Suon, William J. Ray, Guy R. Seabrook, Carmela R. Abraham, Benjamin L. Wolozin · 2008 · Molecular Neurodegeneration
  41. Human apolipoprotein C-I expression in mice impairs learning and memory functions
    Abildayeva, Karlygash, Berbée, Jimmy F.P., Blokland, Arjan, Jansen, Paula J., Hoek, Frans J., Meijer, Onno, Lütjohann, Dieter, Gautier, Thomas, Pillot, Thierry, De Vente, Jan et al. · 2008 · Journal of Lipid Research
  42. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer’s Disease Pathogenesis
    Borràs, Carla, Mercer, Aina, Sirisi, Sònia, Alcolea, Daniel, Escolà-Gil, Joan Carles, Blanco-Vaca, Francisco, Tondo, Mireia · 2022 · International Journal of Molecular Sciences
  43. Dietary Patterns, Genes, and Health: Challenges and Obstacles to be Overcome
    Alexis C. Wood · 2014 · Current Nutrition Reports
  44. Exploration of genetic susceptibility factors for Parkinson’s disease in a South American sample
    Bruno A. Benítez, Diego A. Forero, Gonzálo Arboleda, Luis A. Granados, Juan José Yunis, William Fernández, Humberto Arboleda · 2010 · Journal of Genetics
  45. Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
    Todd Eliot Golde, Wolfgang J. Streit, Paramita Chakrabarty · 2013 · Alzheimer s Research & Therapy
  46. An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3
    Todd L. Edwards, Margaret Ann Pericak‐Vance, Johnny R. Gilbert, Jonathan L. Haines, Eden R. Martin, Marylyn DeRiggi Ritchie · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  47. CR1 genotype is associated with entorhinal cortex volume in young healthy adults
    Janita Bralten, Barbara Franke, Alejandro Arias Vásquez, Angelien J.G.A.M. Heister, Han G. Brunner, Guillén Fernández, Mark Rijpkema · 2011 · Neurobiology of Aging
  48. Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer’s Disease
    Simone Lista, Zaven S. Khachaturian, Dan Rujescu, Francesco Garaci, Bruno Dubois, Harald Juergen Hampel · 2015 · Methods in molecular biology
  49. Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation
    Sajad Fakhri, Sana Piri, Seyed Zachariah Moradi, Haroon Zaman Khan · 2021 · Current Neuropharmacology
  50. Neuroinflammatory Cytokines - The Common Thread in Alzheimer Pathogenesis
    W. Sue T. Griffin, Steven W. Barger, Dillard Professor and Vice Chairman · 2011 · European Neurological Review
  51. Different Atrophic Patterns in Early- and Late-Onset Alzheimer’s Disease and Evaluation of Clinical Utility of a Method of Regional z-Score Analysis Using Voxel-Based Morphometry
    Akihiko Shiino, Toshiyuki Watanabe, Tadashi Kitagawa, Emi Kotani, June Takahashi, Shigehiro Morikawa, Ichiro Akiguchi · 2008 · Dementia and Geriatric Cognitive Disorders
  52. Influence of Variation in the Follicle-Stimulating Hormone Receptor Gene (FSHR) and Age at Menopause on the Development of Alzheimer’s Disease in Women
    Rosa Maria Corbo, Giuseppe Gambina, Elisabetta Broggio, Renato Scacchi · 2011 · Dementia and Geriatric Cognitive Disorders
  53. Application of Artificial Neural Networks to Investigate One-Carbon Metabolism in Alzheimer’s Disease and Healthy Matched Individuals
    Fabio Coppedè, Enzo Grossi, Massimo Buscema, Lucia Migliore · 2013 · PLoS ONE
  54. Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders
    Christopher Carter · 2013 · Pathogens and Disease
  55. Estrogen receptor polymorphisms and incident dementia: The prospective 3C study
    Joanne L. Ryan, Isabelle Carrière, Laure Carcaillon‐Bentata, Jean‐François Dartigues, Sophie Auriacombe, Olivier Rouaud, Claudine Berr, Karen A. Ritchie, Pierre‐Yves Scarabin, Marie‐Laure Ancelin · 2013 · Alzheimer s & Dementia
  56. Impact of Common KIBRA Allele on Human Cognitive Functions
    Heike Wersching, Katrin Guske, Sandra Hasenkamp, Claudia Hagedorn, S Schiwek, S Jansen, A. Veronica Witte, Jürgen Wellmann, Hubertus Lohmann, Kerstin Duning et al. · 2011 · Neuropsychopharmacology
  57. Analysis of proteins that rapidly change upon mechanistic/mammalian target of rapamycin complex 1 (mTORC1) repression identifies parkinson protein 7 (PARK7) as a novel protein aberrantly expressed in tuberous sclerosis complex (TSC)
    Niere, Farr, Namjoshi, Sanjeev, Song, Ehwang, Dilly, Geoffrey A., Schoenhard, Grant, Zemelman, Boris V., Mechref, Yehia, Raab-Graham, Kimberly F. · 2016 · Molecular & Cellular Proteomics
  58. Identification of Alzheimer's Disease-Related Genes Based on Data Integration Method
    Yang Hu, Tianyi Zhao, Tianyi Zang, Ying Zhang, Liang Cheng · 2019 · Frontiers in Genetics
  59. Gene networks and systems biology in Alzheimer's disease: Insights from multi‐omics approaches
    Negin Rahimzadeh, Shushrruth Sai Srinivasan, Jing Zhang, Vivek Swarup · 2024 · Alzheimer s & Dementia
  60. Analyzing Large-Scale Samples Confirms the Association Between the ABCA7 rs3764650 Polymorphism and Alzheimer’s Disease Susceptibility
    Guiyou Liu, Fujun Li, Shuyan Zhang, Yongshuai Jiang, Guoda Ma, Hong Shang, Jiafeng Liu, Rennan Feng, Liangcai Zhang, Mingzhi Liao et al. · 2014 · Molecular Neurobiology
  61. CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer’s disease in the Chinese Han population
    Huacheng Yan, Yanying Kong, Baoxia He, Mukun Huang, Jian Li, Jiaqiang Zheng, Lei Liang, Jianjun Bi, Shujin Zhao, Lei Shi · 2015 · Neuroscience Letters
  62. Altered SPMs and age‐associated decrease in brain DHA in APOE4 female mice
    Anneloes Martinsen, Noemı́ Tejera, David Vauzour, Glenn Harden, James Dick, Sujata Shinde, Anne E. Barden, Trevor Anthony Mori, Anne Marie Minihane · 2019 · The FASEB Journal
  63. Apolipoprotein E ε4 Allele Interacts with Sex and Cognitive Status to Influence All‐Cause and Cause‐Specific Mortality in U.S. Older Adults
    May A. Beydoun, Hind A. Beydoun, Jay S. Kaufman, Yang An, Susan M. Resnick, Richard O’Brien, Luigi Ferrucci, Alan B. Zonderman · 2013 · Journal of the American Geriatrics Society
  64. Polymorphisms of the estrogen receptor α (ESR1) gene and the risk of Alzheimer's disease in a southern Chinese community
    Suk L. Ma, Nelson L.S. Tang, Cindy W. C. Tam, Victor Wing-Cheong Lui, Edmond S. S. Lau, Ya P. Zhang, Helen F.K. Chiu, LINDA C. W. LAM · 2009 · International Psychogeriatrics
  65. Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia
    Andrew H. Ford, Leon A Flicker, Helman S. Alfonso, Graeme J. Hankey, Paul E. Norman, Frank M. VAN BOCKXMEER, Osvaldo P. Almeida · 2011 · Journal of Neurology Neurosurgery & Psychiatry
  66. Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer’s disease dementia: A systematic review and meta-analysis
    Leonie C. P. Banning, Inez H.G.B. Ramakers, Kay Deckers, Frans R.J. Verhey, Pauline Aalten · 2018 · Neuroscience & Biobehavioral Reviews
  67. Alzheimer’s disease: diagnostics, prognostics and the road to prevention
    Grossman, Iris, Lutz, Michael W., Crenshaw, Donna G., Saunders, Ann M., Burns, Daniel K., Roses, Allen D. · 2010 · EPMA Journal
  68. Genetic Cross-Interaction between APOE and PRNP in Sporadic Alzheimer's and Creutzfeldt-Jakob Diseases
    Olga Calero, Maria Jesus Bullido, Jordi Clarimón, Ana Frank, Pablo Martínez‐Martín, Alberto Lleó, Maria Jesus Rey, Alberto Rábano, Rafael Blesa, Teresa Gómez‐Isla et al. · 2011 · PLoS ONE
  69. SORL1 is Genetically Associated with Neuropathologically Characterized Late-Onset Alzheimer's Disease
    Yanan Wen, Japanese Alzheimer's Disease Neuroimaging Initiative, Akinori Miyashita, Nobutaka Kitamura, Tamao Tsukie, Yuko Saito, Hiroyuki Hatsuta, Shigeo Murayama, Akiyoshi Kakita, Hitoshi Takahashi et al. · 2013 · Journal of Alzheimer s Disease
  70. Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer’s Biomarker
    Kamrul Islam, Samar Damiati, Jagriti Sethi, Ahmed M. Suhail, Genhua Pan · 2018 · Sensors
  71. Species-Specific Changes in a Primate Transcription Factor Network Provide Insights into the Molecular Evolution of the Primate Prefrontal Cortex
    Stefano Berto, Katja Nowick · 2018 · Genome Biology and Evolution
  72. Potential Role of OERP as Early Marker of Mild Cognitive Impairment
    Sara Invitto, Giulia Piraino, Vincenzo Ciccarese, Laura Carmillo, Marcella Caggiula, Giorgio Trianni, Giuseppe Nicolardi, Santo Di Nuovo, Michela Balconi · 2018 · Frontiers in Aging Neuroscience
  73. Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer
    Zahra Montazeri, Xue Li, Christine Nyiraneza, Xiangyu Ma, Maria N Timofeeva, Victoria Svinti, Xiangrui Meng, Yazhou He, Yacong Bo, Samuel B. Morgan et al. · 2019 · Gut
  74. Alzheimers sykdom – diagnostikk og behandling
    Anne‐Brita Knapskog, Knut Engedal, Geir Selbæk, Anne‐Rita Öksengård · 2021 · Tidsskrift for Den norske legeforening
  75. Race-Related Association between APOE Genotype and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Wei Qin, Wenwen Li, Qi Wang, Min Gong, Tingting Li, Yuqing Shi, Yang Song, Ying Li, Fangyu Li, Jianping Jia · 2021 · Journal of Alzheimer s Disease
  76. Epigenetic drugs in Alzheimer’s disease
    Mar Cuadrado‐Tejedor, Julen Oyarzábal, María Pascual‐Lucas, Rafael Franco, Ana García‐Osta · 2013 · BioMolecular Concepts
  77. The apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging
    Florence F. Roussotte, Boris A. Gutman, Sarah K. Madsen, John B. Colby, Katherine L. Narr, Paul M. Thompson · 2013 · Neurobiology of Aging
  78. The TOMM40 gene rs2075650 polymorphism contributes to Alzheimer’s disease in Caucasian, and Asian populations
    Hao Huang, Jun Yang Zhao, Biyun Xu, Xu Ma, Qiaoyun Dai, Taishun Li, Fangjing Xue, Bingwei Chen · 2016 · Neuroscience Letters
  79. Alzheimer's Disease—Current Status and Future Directions
    Deepshikha Bhardwaj, Connie Mitra, Chandrakala Aluganti Narasimhulu, Aladdin Riad, Mitsushita Doomra, Sampath Parthasarathy · 2017 · Journal of Medicinal Food
  80. Genetics of Alzheimer's Disease
    Lars Bertram, Rudolph E. Tanzi · 2011 · Wiley eBooks
  81. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease
    Olivier C. Maes, Hyman M. Schipper, George Chong, Howard Mark Chertkow, Eugenia Wang · 2008 · Neurobiology of Aging
  82. Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease
    Joanna Żukowska, Stephen J. Moss, Vasanta Subramanian, K. Ravi Acharya · 2023 · FEBS Journal
  83. Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
    Hui Wang, Timothy S. Chang, Beth A. Dombroski, Po‐Liang Cheng, Vishakha Patil, Leopoldo Valiente‐Banuet, Kurt W. Farrell, Catriona McLean, Laura Molina‐Porcel, Alex H. Rajput et al. · 2024 · Molecular Neurodegeneration
  84. Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese
    Qun Zhang, Jin‐Tai Yu, Ping Wang, Wei Chen, Zhong‐Chen Wu, Hong Fu Jiang, Lan Tan · 2010 · Brain Research
  85. Interactions between genetic admixture, ethnic identity, APOE genotype and dementia prevalence in an admixed Cuban sample; a cross-sectional population survey and nested case-control study
    Beatríz Marcheco Teruel, Juan J. Llibre Rodríguez, Paul McKeigue, Teresa Collazo Mesa T, Evelyn Fuentes, Adolfo Valhuerdi, Milagros A. Guerra Hernández, J. R. M. Copeland, Cleusa P. Ferri, Martin James Prince · 2011 · BMC Medical Genetics
  86. Integrative analysis of multi-dimensional imaging genomics data for Alzheimer's disease prediction
    Ziming Zhang, Heng Huang, Dinggang G. Shen, Alzheimer’s Disease Neuroimaging Initiative · 2014 · Frontiers in Aging Neuroscience
  87. Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction
    Chuan‐Yun Li, Wei-Zhen Zhou, Ping-Wu Zhang, Catherine Johnson, Liping Wei, George R. Uhl · 2011 · BMC Genomics
  88. Identification of novel immune‐relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis
    Zhijie Han, Weiwei Xue, Lin Tao, Feng Zhu · 2018 · CNS Neuroscience & Therapeutics
  89. Genome-wide profiling and predicted significance of post-mortem brain microRNA in Alzheimer’s disease
    Adriane Dallanora Henriques, Wilcelly Machado‐Silva, Renata Elaine Paraízo Leite, Cláudia Kimie Suemoto, Kátia Ramos Moreira Leite, Miguel Srougi, Alexandre C. Pereira, Wilson Jacob Filho, Otávio de Tolêdo Nóbrega · 2020 · Mechanisms of Ageing and Development
  90. APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia
    Jonathan Blackman, Seth Love, Lindsey Isla Sinclair, Richard Cain, Elizabeth Jane Coulthard · 2022 · Alzheimer s Research & Therapy
  91. Plasma Cystatin C and Risk of Developing Alzheimer's Disease in Subjects with Mild Cognitive Impairment
    Roberta Ghidoni, Luisa Benussi, Michela Glionna, Silvia Desenzani, Valentina Albertini, Efrat Levy, Enzo Emanuele, Giuliano Gb. Binetti · 2010 · Journal of Alzheimer s Disease
  92. Invertebrate Models of Alzheimer's Disease
    Siddhita D. Mhatre, Brie E. Paddock, Aleister J. Saunders, Daniel R. Marenda · 2012 · Journal of Alzheimer s Disease
  93. Tissue-based Alzheimer gene expression markers–comparison of multiple machine learning approaches and investigation of redundancy in small biomarker sets
    Lena Scheubert, Mitja Luštrek, Rainer Schmidt, Dirk Repsilber, Georg Fuellen · 2012 · BMC Bioinformatics
  94. Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies
    Ariana P. Gatt, Emma L. Jones, Paul T. Francis, Clive G. Ballard, J.E. Bateman · 2013 · Neuroscience Letters
  95. Human Pathway-Based Disease Network
    Liang Yu, Lin Gao · 2017 · IEEE Transactions on Computational Biology and Bioinformatics
  96. Artificial intelligence for neurodegenerative experimental models
    Sarah J. Marzi, Brian M. Schilder, Alexi Nott, Carlo Sala Frigerio, Sandrine Willaime‐Morawek, Magda Bucholc, Diane P. Hanger, Charlotte R. James, Patrick Alfryn Lewis, Ilianna Lourida et al. · 2023 · Alzheimer s & Dementia
  97. Identifying key genetic variants in Alzheimer’s disease progression using Graph Convolutional Networks (GCN) and biological impact analysis
    Belal A. Hamed, Heba Mamdouh Farghaly, Omar Abdelaziz Ahmed, Tarek Abd El‐Hafeez · 2025 · Journal Of Big Data
  98. Characterization of Insulin Degrading Enzyme and Other Amyloid-β Degrading Proteases in Human Serum: A Role in Alzheimer's Disease?
    Zhiheng Liu, Haihao Zhu, Guang Fang, Kathryn Rose Walsh, Mkaya Mwamburi, Benjamin L. Wolozin, Samer O. Abdul‐Hay, Tsuneya Ikezu, Malcolm A. Leissring, Wei Qiao Qiu · 2012 · Journal of Alzheimer s Disease
  99. An emerging role for Ubiquilin 1 in regulating protein quality control system and in disease pathogenesis.
    Can Martin Zhang, Aleister J. Saunders · 2009 · PubMed
  100. Genome-wide and gene-based association implicates FRMD6 in alzheimer disease
    Mun‐Gwan Hong, Chandra A. Reynolds, Adina Leiah Feldman, Mikael Kallin, Jean‐Charles Lambert, Philippe Amouyel, Erik Ingelsson, Nancy L. Pedersen, Jonathan A. Prince · 2011 · Human Mutation